BBIO Deferred Revenue

Bridgebio Pharma Inc · Deferred Revenue

BBIO logo

BBIO Deferred Revenue

Latest reported$20.27M
BBIO FY Deferred Revenue ($0.00 → $20.27M)
High-resolution chart · PNG

BBIO deferred revenue history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc Deferred Revenue — Annual fiscal periods (USD)
Period endingDeferred Revenue (USD)
20,270,000
0
6,096,000
8,156,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.